1 | N acetyl cysteine | - | - | - | - | 2件: 6 6, 19 💬
|
2 | N acetyl L cysteine | - | - | - | - | 1件: 60 60 💬
|
3 | N acetyl L leucine | - | - | - | - | 1件: 19 19 💬
|
4 | N acetylcysteine | - | - | - | - | 1件: 13 13 💬
|
5 | N''-[(E)-[(2E)-3-[1-(2-nitrophenyl)-1H-pyrrol-2-YL]PROP-2-EN-1-ylidene]amino]guanidinium acetate | - | - | - | - | 1件: 46 46 💬
|
6 | N(4,5BIS methanesulfonyl2methylbenzoyl) guanidine hydrochloride monohydrate | - | - | - | - | 1件: 113 113 💬
|
7 | N-(4,5-BIS methanesulfonyl-2-methyl-benzoyl)guanidine hydrochloride monohydrate | - | - | - | - | 1件: 113 113 💬
|
8 | N-(5-hydroxy-2,4- BIS(trimethylsilyl)phenyl)-4-OXO- 1,4-dihydroquinoline-3-carboxamide | - | - | - | - | 1件: 299 299 💬
|
9 | N-(5-hydroxy-2,4-BIS(trimethylsilyl)phenyl)-4-OXO-1,4-dihydroquinoline-3-carboxamide | - | - | - | - | 1件: 299 299 💬
|
10 | N-(5-{4-[(3,3-dimethyl-1-azetidinyl)carbonyl]phenyl}[1,2,4]triazolo[1,5-A]pyridin-2-YL)cyclopropanecarboxamide | - | - | - | - | 1件: 49 49 💬
|
11 | N-(trans-3-(5-((R)-1-hydroxyethyl)-1,3,4-oxadiazol-2-YL)cyclobutyl)-3-phenylisoxazole-5-carboxamide | - | - | - | - | 1件: 299 299 💬
|
12 | N-0923 | - | - | - | - | 1件: 6 6 💬
|
13 | N-3 LC-pufa | - | - | - | - | 1件: 46 46 💬
|
14 | N-3 polyunsaturated fatty acids | - | - | - | - | 1件: 96 96 💬
|
15 | N-[1-((5-cyanopyridin-2-YL)methyl)-1H-pyrazol-3-YL]-2-[4-(1-(trifluoromethyl)cyclopropyl)phenyl]acetamide | - | - | - | - | 1件: 154 154 💬
|
16 | N-acetyl cysteine | - | - | - | - | 6件: 13 13, 34, 85, 88, 296, 310 💬
|
17 | N-acetyl-cysteine | - | - | - | - | 1件: 84 84 💬
|
18 | N-acetyl-L leucine | - | - | - | - | 1件: 19 19 💬
|
19 | N-acetyl-L-leucine | 1件: L-Acetylleucine L-Acetylleucine | - | - | - | 2件: 19 19, 65 💬
|
20 | N-acetylcystein | - | - | - | - | 1件: 299 299 💬
|
21 | N-acetylcysteine | 1件: Acetylcysteine Acetylcysteine | 1件: Acetylcysteine
Acetylcysteine
💬
| - | - | 14件: 6 6, 13, 19, 20, 21, 49, 58, 85, 90, 111, 164, 296, 299, 337 💬
|
22 | N-acetylcysteine amide | - | - | - | - | 1件: 19 19 💬
|
23 | N-acetylcysteine capsule | - | - | - | - | 1件: 6 6 💬
|
24 | N-acetylcysteine syrup | - | - | - | - | 1件: 53 53 💬
|
25 | N-acetylgalactosamine 4-sulfatase | - | - | - | - | 1件: 19 19 💬
|
26 | N-acetylneuraminic acid | - | - | - | - | 1件: 30 30 💬
|
27 | N-carbamylglutamate | 1件: Carglumic acid Carglumic acid | 1件: Carglumic acid
Carglumic acid
💬
| 1件: CPS1 CPS1 💬
| 3件: Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Arginine biosynthesis, Nitrogen metabolism 💬 | 2件: 245 245, 246 💬
|
28 | N-methyl D-(2,3,4,5,6-pentahydroxy-hexyl)-ammonium | - | - | - | - | 1件: 28 28 💬
|
29 | N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine | - | - | - | - | 1件: 13 13 💬
|
30 | N-thymidine | - | - | - | - | 2件: 215 215, 216 💬
|
31 | N-{4-chloro-2-[(1-oxido-4-pyridinyl)carbonyl]phenyl}-4-(1,1-dimethylethyl)benzenesulfonamide, sodium | - | - | - | - | 1件: 96 96 💬
|
32 | N-{4-chloro-2-[(1-oxido-4-pyridinyl)carbonyl]phenyl}-4-(1,1-dimethylethyl)benzenesulfonamidesodium | - | - | - | - | 1件: 96 96 💬
|
33 | N. meningitidis group C (strain C11) oligosaccharide conjugated TO corynebacterium diphtheriae CRM197 adsorbed ON aluminum hydroxide | - | - | - | - | 1件: 11 11 💬
|
34 | N. meningitidis group C polysaccharide | - | - | - | - | 1件: 14 14 💬
|
35 | N. meningitidis group W135 oligosaccharide conjugated CRM197 | - | - | - | - | 1件: 13 13 💬
|
36 | N/A | - | - | - | - | 1件: 61 61 💬
|
37 | N02bg10 | - | - | - | - | 1件: 13 13 💬
|
38 | N03ax12 | - | - | - | - | 1件: 13 13 💬
|
39 | N04bc07 | - | - | - | - | 1件: 6 6 💬
|
40 | N04bd02 | - | - | - | - | 1件: 6 6 💬
|
41 | N04bd03 | - | - | - | - | 1件: 6 6 💬
|
42 | N06dx01 | - | - | - | - | 1件: 13 13 💬
|
43 | N1,N3-BIS(2-mercaptoethyl) isophthalamide | - | - | - | - | 2件: 5 5, 17 💬
|
44 | N15-thymidine | - | - | - | - | 1件: 215 215 💬
|
45 | N6022 | - | - | - | - | 1件: 299 299 💬
|
46 | N91115 | - | - | - | - | 1件: 299 299 💬
|
47 | NA | - | - | - | - | 1件: 58 58 💬
|
48 | NA18F | - | - | - | - | 1件: 13 13 💬
|
49 | Nabilone | 1件: Nabilone Nabilone | 1件: Nabilone
Nabilone
💬
| 2件: CNR1 CNR1, CNR2 💬
| 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 4件: 6 6, 13, 97, 127 💬
|
50 | Nabilone 0.25 MG | 1件: Nabilone Nabilone | 1件: Nabilone
Nabilone
💬
| 2件: CNR1 CNR1, CNR2 💬
| 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 1件: 6 6 💬
|
51 | Nabiximols | 1件: Nabiximols Nabiximols | 1件: Nabiximols
Nabiximols
💬
| - | - | 1件: 13 13 💬
|
52 | Nabiximols - sativex | 3件: Cannabidiol Cannabidiol, Dronabinol, Nabiximols | 3件: Dronabinol
Dronabinol
,
Nabiximols
,
Cannabidiol
💬
| 2件: CNR1 CNR1, CNR2 💬
| 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 1件: 13 13 💬
|
53 | NAC | - | - | - | - | 6件: 8 8, 34, 51, 85, 90, 299 💬
|
54 | NAC effervescent tablets | - | - | - | - | 1件: 90 90 💬
|
55 | Nacl | - | - | - | - | 1件: 227 227 💬
|
56 | Nacom | - | - | - | - | 1件: 6 6 💬
|
57 | Nacom 100 | - | - | - | - | 1件: 6 6 💬
|
58 | Nacom levodopa+cardidopa | - | - | - | - | 1件: 6 6 💬
|
59 | Nacystelyn | 1件: Nacystelyn Nacystelyn | - | - | - | 1件: 299 299 💬
|
60 | Nadh | 1件: NADH NADH | - | - | - | 1件: 302 302 💬
|
61 | Nadolol | 1件: Nadolol Nadolol | 1件: Nadolol
Nadolol
💬
| 2件: ADRB1 ADRB1, ADRB2 💬
| 13件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 6 6 💬
|
62 | Naglazyme | 1件: Galsulfase Galsulfase | 1件: Galsulfase
Galsulfase
💬
| 1件: ARSB ARSB 💬
| 2件: Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome 💬 | 1件: 19 19 💬
|
63 | NAL | - | - | - | - | 2件: 6 6, 299 💬
|
64 | NAL ER | - | - | - | - | 1件: 85 85 💬
|
65 | Nalbuphine ER 108 MG | 1件: Nalbuphine Nalbuphine | 2件: Nalbuphine hydrochloride
Nalbuphine hydrochloride
,
Nalbuphine
💬
| 3件: OPRD1 OPRD1, OPRK1, OPRM1 💬
| 7件: Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 85 85 💬
|
66 | Nalbuphine ER 27 MG | 1件: Nalbuphine Nalbuphine | 2件: Nalbuphine hydrochloride
Nalbuphine hydrochloride
,
Nalbuphine
💬
| 3件: OPRD1 OPRD1, OPRK1, OPRM1 💬
| 7件: Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 85 85 💬
|
67 | Nalbuphine ER 54 MG | 1件: Nalbuphine Nalbuphine | 2件: Nalbuphine hydrochloride
Nalbuphine hydrochloride
,
Nalbuphine
💬
| 3件: OPRD1 OPRD1, OPRK1, OPRM1 💬
| 7件: Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 85 85 💬
|
68 | Nalbuphine extended-realease (ER) tablets | 1件: Nalbuphine Nalbuphine | 2件: Nalbuphine hydrochloride
Nalbuphine hydrochloride
,
Nalbuphine
💬
| 3件: OPRD1 OPRD1, OPRK1, OPRM1 💬
| 7件: Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 85 85 💬
|
69 | Nalbuphine extended-release (ER) tablets | 1件: Nalbuphine Nalbuphine | 2件: Nalbuphine hydrochloride
Nalbuphine hydrochloride
,
Nalbuphine
💬
| 3件: OPRD1 OPRD1, OPRK1, OPRM1 💬
| 7件: Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 85 85 💬
|
70 | Nalbuphine hydrochloride | 1件: Nalbuphine Nalbuphine | 2件: Nalbuphine hydrochloride
Nalbuphine hydrochloride
,
Nalbuphine
💬
| 3件: OPRD1 OPRD1, OPRK1, OPRM1 💬
| 7件: Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 85 85 💬
|
71 | Nalmefene | 1件: Nalmefene Nalmefene | 3件: Nalmefene hydrochloride
Nalmefene hydrochloride
,
Nalmefene
,
Nalmefene hydrochloride hydrate
💬
| 3件: OPRD1 OPRD1, OPRK1, OPRM1 💬
| 7件: Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 2件: 6 6, 93 💬
|
72 | Naloxone hydrochloride | 1件: Naloxone Naloxone | 3件: Naloxone hydrochloride
Naloxone hydrochloride
,
Naloxone
,
Naloxone hydrochloride dihydrate
💬
| 3件: OPRD1 OPRD1, OPRK1, OPRM1 💬
| 7件: Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 226 226 💬
|
73 | Naloxone hydrochloride dihydrate | 1件: Naloxone Naloxone | 3件: Naloxone hydrochloride
Naloxone hydrochloride
,
Naloxone
,
Naloxone hydrochloride dihydrate
💬
| 3件: OPRD1 OPRD1, OPRK1, OPRM1 💬
| 7件: Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 6 6 💬
|
74 | Naltrexone | 1件: Naltrexone Naltrexone | 2件: Naltrexone hydrochloride
Naltrexone hydrochloride
,
Naltrexone
💬
| 3件: OPRD1 OPRD1, OPRK1, OPRM1 💬
| 7件: Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 5件: 6 6, 10, 13, 96, 226 💬
|
75 | Naltrexone cloridrato | 1件: Naltrexone Naltrexone | 2件: Naltrexone hydrochloride
Naltrexone hydrochloride
,
Naltrexone
💬
| 3件: OPRD1 OPRD1, OPRK1, OPRM1 💬
| 7件: Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 10 10 💬
|
76 | Naltrexone hydrochloride | 1件: Naltrexone Naltrexone | 2件: Naltrexone hydrochloride
Naltrexone hydrochloride
,
Naltrexone
💬
| 3件: OPRD1 OPRD1, OPRK1, OPRM1 💬
| 7件: Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 9件: 10 10, 40, 41, 42, 43, 44, 45, 96, 97 💬
|
77 | Naltrexone-HCL | 1件: Naltrexone Naltrexone | 2件: Naltrexone hydrochloride
Naltrexone hydrochloride
,
Naltrexone
💬
| 3件: OPRD1 OPRD1, OPRK1, OPRM1 💬
| 7件: Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 96 96 💬
|
78 | Namilumab | 1件: Namilumab Namilumab | - | - | - | 2件: 46 46, 84 💬
|
79 | Namisol | - | - | - | - | 2件: 13 13, 298 💬
|
80 | Namuscla | 1件: Mexiletine Mexiletine | 2件: Mexiletine hydrochloride
Mexiletine hydrochloride
,
Mexiletine
💬
| 5件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬
| 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 1件: 114 114 💬
|
81 | Nandrolone | 1件: Nandrolone Nandrolone | 1件: Nandrolone
Nandrolone
💬
| 1件: AR AR 💬
| 4件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬 | 1件: 60 60 💬
|
82 | Nandrolone decanoate | 2件: Nandrolone Nandrolone, Nandrolone decanoate | 2件: Nandrolone decanoate
Nandrolone decanoate
,
Nandrolone
💬
| 1件: AR AR 💬
| 4件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬 | 2件: 60 60, 85 💬
|
83 | Nanobody directed towards THE human A1 domain OF VON willebrand factor | - | - | - | - | 1件: 64 64 💬
|
84 | Nanobubble drink | - | - | - | - | 1件: 46 46 💬
|
85 | Nanocort | - | - | - | - | 3件: 13 13, 46, 97 💬
|
86 | Nanocurcumin | - | - | - | - | 2件: 13 13, 271 💬
|
87 | Nanogam | - | - | - | - | 1件: 63 63 💬
|
88 | Nanogam 100 MG/ML | - | - | - | - | 1件: 65 65 💬
|
89 | Nanogam® 50 MG/ML | - | - | - | - | 1件: 65 65 💬
|
90 | Nanoparticulated rebamipide | 1件: Rebamipide Rebamipide | 1件: Rebamipide
Rebamipide
💬
| - | - | 1件: 46 46 💬
|
91 | NAP | - | - | - | - | 2件: 96 96, 240 💬
|
92 | Napba | - | - | - | - | 1件: 251 251 💬
|
93 | Naprosyn | 1件: Naproxen Naproxen | 2件: Naproxen
Naproxen
,
Naproxen sodium
💬
| 2件: PTGS1 PTGS1, PTGS2 💬
| 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 271 271 💬
|
94 | Naprosyn 500 MG | 1件: Naproxen Naproxen | 2件: Naproxen
Naproxen
,
Naproxen sodium
💬
| 2件: PTGS1 PTGS1, PTGS2 💬
| 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 46 46 💬
|
95 | Naprosysn | - | - | - | - | 1件: 271 271 💬
|
96 | Naproxen | 1件: Naproxen Naproxen | 2件: Naproxen
Naproxen
,
Naproxen sodium
💬
| 2件: PTGS1 PTGS1, PTGS2 💬
| 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 4件: 13 13, 46, 107, 271 💬
|
97 | Naproxen 10 MG/KG | 1件: Naproxen Naproxen | 2件: Naproxen
Naproxen
,
Naproxen sodium
💬
| 2件: PTGS1 PTGS1, PTGS2 💬
| 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 46 46 💬
|
98 | Naproxen oral suspension | 1件: Naproxen Naproxen | 2件: Naproxen
Naproxen
,
Naproxen sodium
💬
| 2件: PTGS1 PTGS1, PTGS2 💬
| 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 46 46 💬
|
99 | Naproxen sodium | 1件: Naproxen Naproxen | 2件: Naproxen
Naproxen
,
Naproxen sodium
💬
| 2件: PTGS1 PTGS1, PTGS2 💬
| 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 107 107 💬
|
100 | Naproxen sodium 550MG tablet | 1件: Naproxen Naproxen | 2件: Naproxen
Naproxen
,
Naproxen sodium
💬
| 2件: PTGS1 PTGS1, PTGS2 💬
| 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 46 46 💬
|
101 | Naproxen tablet 500 MG | 1件: Naproxen Naproxen | 2件: Naproxen
Naproxen
,
Naproxen sodium
💬
| 2件: PTGS1 PTGS1, PTGS2 💬
| 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 46 46 💬
|
102 | Nardil | - | - | - | - | 1件: 6 6 💬
|
103 | Narsoplimab | 1件: Narsoplimab Narsoplimab | 1件: Narsoplimab
Narsoplimab
💬
| 1件: MASP2 MASP2 💬
| 3件: Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, Staphylococcus aureus infection 💬 | 2件: 66 66, 222 💬
|
104 | Nasal aztreonam | - | - | - | - | 1件: 299 299 💬
|
105 | Nasal brushing | - | - | - | - | 1件: 299 299 💬
|
106 | Nasal nitric oxide testing | - | - | - | - | 1件: 340 340 💬
|
107 | Nasal rinsing with xylitol | - | - | - | - | 1件: 299 299 💬
|
108 | Nasojejunal (NJ) tube | - | - | - | - | 1件: 6 6 💬
|
109 | Nasonex | - | - | - | - | 1件: 98 98 💬
|
110 | Nasopharyngeal swabs | - | - | - | - | 1件: 46 46 💬
|
111 | Natalizumab | 1件: Natalizumab Natalizumab | 1件: Natalizumab
Natalizumab
💬
| 1件: ITGA4 ITGA4 💬
| 15件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | 5件: 13 13, 15, 25, 46, 96 💬
|
112 | Natalizumab 300 MG IN 15 ML injection | 1件: Natalizumab Natalizumab | 1件: Natalizumab
Natalizumab
💬
| 1件: ITGA4 ITGA4 💬
| 15件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | 1件: 13 13 💬
|
113 | Natalizumab discontinuation | 1件: Natalizumab Natalizumab | 1件: Natalizumab
Natalizumab
💬
| 1件: ITGA4 ITGA4 💬
| 15件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | 1件: 13 13 💬
|
114 | Natalizumab FOR IV infusion | 1件: Natalizumab Natalizumab | 1件: Natalizumab
Natalizumab
💬
| 1件: ITGA4 ITGA4 💬
| 15件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | 1件: 13 13 💬
|
115 | Natalizumab FOR subcutaneous injection | 1件: Natalizumab Natalizumab | 1件: Natalizumab
Natalizumab
💬
| 1件: ITGA4 ITGA4 💬
| 15件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | 1件: 13 13 💬
|
116 | Natalizumab IV | 1件: Natalizumab Natalizumab | 1件: Natalizumab
Natalizumab
💬
| 1件: ITGA4 ITGA4 💬
| 15件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | 1件: 13 13 💬
|
117 | Natalizumab SC | 1件: Natalizumab Natalizumab | 1件: Natalizumab
Natalizumab
💬
| 1件: ITGA4 ITGA4 💬
| 15件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | 1件: 13 13 💬
|
118 | Natalizumab treatment | 1件: Natalizumab Natalizumab | 1件: Natalizumab
Natalizumab
💬
| 1件: ITGA4 ITGA4 💬
| 15件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | 1件: 13 13 💬
|
119 | Natalizumab/natalizumab-sztn, alemtuzumab, ocrelizumab, rituximab/rituximab-arrx/rituximab-abbs/rituximab-pvvr, cladribine, ofatumumab, ublituximab-xiiy, ocrelizumab and hyaluronidase-ocsq | 1件: Natalizumab Natalizumab | 1件: Natalizumab
Natalizumab
💬
| 1件: ITGA4 ITGA4 💬
| 15件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | 1件: 13 13 💬
|
120 | Natpar | 1件: Parathyroid hormone Parathyroid hormone | 1件: Parathyroid hormone
Parathyroid hormone
💬
| 2件: PTH1R PTH1R, PTHR2 💬
| 4件: Endocrine and other factor-regulated calcium reabsorption Endocrine and other factor-regulated calcium reabsorption, Hormone signaling, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬 | 1件: 235 235 💬
|
121 | Natpara | - | - | - | - | 1件: 235 235 💬
|
122 | Natpara/natpar | - | - | - | - | 1件: 235 235 💬
|
123 | Natriumchlorid | 1件: Sodium chloride Sodium chloride | 1件: Sodium chloride
Sodium chloride
💬
| - | - | 1件: 288 288 💬
|
124 | Natriumklorid 9MG/ML | - | - | - | - | 1件: 46 46 💬
|
125 | Natriuretic peptide | - | - | - | - | 1件: 276 276 💬
|
126 | Natrunix | - | - | - | - | 1件: 46 46 💬
|
127 | Natrunix 400 MG | - | - | - | - | 1件: 46 46 💬
|
128 | Natural herbs OF coconut, aloe vera, and pepperint | - | - | - | - | 1件: 53 53 💬
|
129 | Natural matrix protein (NMP) fibers | - | - | - | - | 1件: 70 70 💬
|
130 | Navenibart | - | - | - | - | 1件: 65 65 💬
|
131 | Navepegritide | - | - | - | - | 1件: 276 276 💬
|
132 | Navocaftor | 1件: Navocaftor Navocaftor | 1件: Navocaftor
Navocaftor
💬
| 1件: CFTR CFTR 💬
| 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 💬
|
133 | NBI-5788 | - | - | - | - | 1件: 13 13 💬
|
134 | NBI-74788 | - | - | - | - | 1件: 81 81 💬
|
135 | NBI-77860 | - | - | - | - | 1件: 81 81 💬
|
136 | NBI-827104 | - | - | - | - | 1件: 154 154 💬
|
137 | Nbmi | - | - | - | - | 2件: 5 5, 17 💬
|
138 | NBT-NM108 | - | - | - | - | 1件: 193 193 💬
|
139 | NBTX-001 | - | - | - | - | 1件: 6 6 💬
|
140 | NC 1 cell therapy | - | - | - | - | 1件: 117 117 💬
|
141 | NCA 500MG | - | - | - | - | 1件: 93 93 💬
|
142 | ND-L02-S0201 FOR injection | - | - | - | - | 1件: 85 85 💬
|
143 | ND0611 | - | - | - | - | 1件: 6 6 💬
|
144 | ND0612 | - | - | - | - | 1件: 6 6 💬
|
145 | ND0612 (levodopa/carbidopa solution) + morning oral IR-LD/CD | 1件: Levodopa Levodopa | 1件: Levodopa
Levodopa
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
146 | ND0612 solution FOR SC infusion | - | - | - | - | 1件: 6 6 💬
|
147 | ND1421 | - | - | - | - | 1件: 6 6 💬
|
148 | ND1587 | - | - | - | - | 1件: 6 6 💬
|
149 | ND1589 | - | - | - | - | 1件: 6 6 💬
|
150 | ND1590 | - | - | - | - | 1件: 6 6 💬
|
151 | ND1702 | - | - | - | - | 1件: 6 6 💬
|
152 | NDV-3A | - | - | - | - | 1件: 65 65 💬
|
153 | NDX-3315 and NDX-3324 | 1件: NDX-3315 NDX-3315 | - | - | - | 1件: 98 98 💬
|
154 | NE3107 | - | - | - | - | 1件: 6 6 💬
|
155 | NEAR-infrared-induced autofluorescence and indocyanine green NEAR-infrared angiography | - | - | - | - | 1件: 235 235 💬
|
156 | NEB/01-07 | - | - | - | - | 1件: 299 299 💬
|
157 | Nebcin | - | - | - | - | 1件: 299 299 💬
|
158 | Nebcinal | - | - | - | - | 1件: 299 299 💬
|
159 | Nebcinal tobi | - | - | - | - | 1件: 299 299 💬
|
160 | Nebcine | - | - | - | - | 1件: 299 299 💬
|
161 | Nebicapone | 1件: Nebicapone Nebicapone | - | - | - | 1件: 6 6 💬
|
162 | Nebido | - | - | - | - | 1件: 13 13 💬
|
163 | Nebido® testosterone undecanoate 1000 MG/4 ML solution FOR injection | - | - | - | - | 1件: 13 13 💬
|
164 | Nebivolol | 1件: Nebivolol Nebivolol | 2件: Nebivolol
Nebivolol
,
Nebivolol hydrochloride
💬
| 1件: ADRB1 ADRB1 💬
| 13件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 3件: 85 85, 113, 167 💬
|
165 | Nebivolol 5 MG | 1件: Nebivolol Nebivolol | 2件: Nebivolol
Nebivolol
,
Nebivolol hydrochloride
💬
| 1件: ADRB1 ADRB1 💬
| 13件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 17 17 💬
|
166 | Nebulization tobramycin | 1件: Tobramycin Tobramycin | 2件: Tobramycin
Tobramycin
,
Tobramycin sulfate
💬
| - | - | 1件: 299 299 💬
|
167 | Nebulized combination ipratropium bromide with salbutamol | - | - | - | - | 1件: 86 86 💬
|
168 | Nebulized ensifentrine suspension | - | - | - | - | 1件: 299 299 💬
|
169 | Nebulized ipratropium bromide | - | - | - | - | 1件: 86 86 💬
|
170 | Nebulizer | - | - | - | - | 1件: 6 6 💬
|
171 | Nedosiran | 1件: Nedosiran Nedosiran | 1件: Nedosiran sodium
Nedosiran sodium
💬
| 1件: LDH LDH 💬
| 7件: Central carbon metabolism in cancer Central carbon metabolism in cancer, Cysteine and methionine metabolism, Glucagon signaling pathway, Glycolysis / Gluconeogenesis, HIF-1 signaling pathway, Propanoate metabolism, Pyruvate metabolism 💬 | 1件: 234 234 💬
|
172 | Needle biopsy OF THE vastus lateralis muscle | - | - | - | - | 1件: 113 113 💬
|
173 | Nefecon | - | - | - | - | 1件: 66 66 💬
|
174 | Nefecon 16MG daily | - | - | - | - | 1件: 66 66 💬
|
175 | Neflamapimod | 1件: Neflamapimod Neflamapimod | 1件: Neflamapimod
Neflamapimod
💬
| 4件: P38 P38, P38, P38, P38 💬
| 62件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Alcoholic liver disease, Amyotrophic lateral sclerosis, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Dopaminergic synapse, Efferocytosis, Epithelial cell signaling in Helicobacter pylori infection, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hepatitis B, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, IL-17 signaling pathway, Inflammatory mediator regulation of TRP channels, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Leukocyte transendothelial migration, Lipid and atherosclerosis, MAPK signaling pathway, NOD-like receptor signaling pathway, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Oocyte meiosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Platelet activation, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rap1 signaling pathway, Relaxin signaling pathway, Retrograde endocannabinoid signaling, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Thermogenesis, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, VEGF signaling pathway, Yersinia infection 💬 | 1件: 8 8 💬
|
176 | Neisseria meningitidis group A polysaccharide conjugated with tetanus toxoid carrier protein | 1件: Clostridium tetani toxoid antigen (formaldehyde inactivated) Clostridium tetani toxoid antigen (formaldehyde inactivated) | 2件: Tetanus toxoid adsorbed
Tetanus toxoid adsorbed
,
Tetanus toxoid
💬
| - | - | 1件: 50 50 💬
|
177 | Neisseria meningitidis group W-135 polysaccharide conjugated TO teta | - | - | - | - | 1件: 50 50 💬
|
178 | Neisseria meningitidis group W-135 polysaccharide conjugated TO tetanus toxoid carrier protein | 1件: Clostridium tetani toxoid antigen (formaldehyde inactivated) Clostridium tetani toxoid antigen (formaldehyde inactivated) | 2件: Tetanus toxoid adsorbed
Tetanus toxoid adsorbed
,
Tetanus toxoid
💬
| - | - | 1件: 50 50 💬
|
179 | Nelfinavir | 1件: Nelfinavir Nelfinavir | 2件: Nelfinavir mesylate
Nelfinavir mesylate
,
Nelfinavir
💬
| - | - | 3件: 49 49, 265, 331 💬
|
180 | Nelfinavir mesylate | 1件: Nelfinavir Nelfinavir | 2件: Nelfinavir mesylate
Nelfinavir mesylate
,
Nelfinavir
💬
| - | - | 1件: 265 265 💬
|
181 | Nelotanserin | 1件: Nelotanserin Nelotanserin | 1件: Nelotanserin
Nelotanserin
💬
| 1件: HTR2 HTR2 💬
| 6件: Calcium signaling pathway Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse 💬 | 1件: 6 6 💬
|
182 | Nemolizumab | 1件: Nemolizumab Nemolizumab | 1件: Nemolizumab
Nemolizumab
💬
| 1件: IL31RA IL31RA 💬
| 2件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬 | 1件: 51 51 💬
|
183 | NEO-ASA | - | - | - | - | 1件: 251 251 💬
|
184 | NEO-GAA | - | - | - | - | 1件: 256 256 💬
|
185 | NEO-recormon | - | - | - | - | 1件: 18 18 💬
|
186 | NEOD001 | - | - | - | - | 1件: 28 28 💬
|
187 | Neofordex | 1件: Dexamethasone Dexamethasone | 3件: Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 63 63 💬
|
188 | Neofuse | 1件: Rexlemestrocel-L Rexlemestrocel-L | - | - | - | 1件: 70 70 💬
|
189 | Neogaa | 1件: Avalglucosidase alfa Avalglucosidase alfa | 1件: Avalglucosidase alfa
Avalglucosidase alfa
💬
| 1件: GAA GAA 💬
| 3件: Galactose metabolism Galactose metabolism, Lysosome, Starch and sucrose metabolism 💬 | 1件: 256 256 💬
|
190 | Neogaa or avalglucosidase alfa | 1件: Avalglucosidase alfa Avalglucosidase alfa | 1件: Avalglucosidase alfa
Avalglucosidase alfa
💬
| 1件: GAA GAA 💬
| 3件: Galactose metabolism Galactose metabolism, Lysosome, Starch and sucrose metabolism 💬 | 1件: 256 256 💬
|
191 | Neokare breast milk fortifier | - | - | - | - | 1件: 291 291 💬
|
192 | Neomycin | 1件: Neomycin Neomycin | 3件: Neomycin sulfate
Neomycin sulfate
,
Neomycin palmitate
,
Neomycin
💬
| - | - | 3件: 96 96, 97, 296 💬
|
193 | Neophyr 1000PPM MOL/MOL | - | - | - | - | 1件: 294 294 💬
|
194 | Neoral | 1件: Cyclosporine Cyclosporine | 1件: Cyclosporine
Cyclosporine
💬
| 5件: PPP3C PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
| 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 3件: 60 60, 97, 222 💬
|
195 | Neoral 100 MG, capsule molle | - | - | - | - | 1件: 60 60 💬
|
196 | Neoral oral solution | 1件: Cyclosporine Cyclosporine | 1件: Cyclosporine
Cyclosporine
💬
| 5件: PPP3C PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
| 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 269 269 💬
|
197 | Neoral soft gelatin capsules | 1件: Cyclosporine Cyclosporine | 1件: Cyclosporine
Cyclosporine
💬
| 5件: PPP3C PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
| 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 2件: 97 97, 269 💬
|
198 | Neorecormon | 2件: Epoetin beta Epoetin beta, Erythropoietin | 5件: Epoetin alfa
Epoetin alfa
,
Epoetin beta
,
Epoetin epsilon
,
Epoetin theta
,
Epoetin zeta
💬
| 1件: EPOR EPOR 💬
| 7件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Efferocytosis, Hematopoietic cell lineage, Hormone signaling, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 2件: 13 13, 18 💬
|
199 | Neostigmine | 1件: Neostigmine Neostigmine | 3件: Neostigmine bromide
Neostigmine bromide
,
Neostigmine methylsulfate
,
Neostigmine
💬
| 1件: ACHE ACHE 💬
| 3件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬 | 1件: 11 11 💬
|
200 | Neovasculgen | - | - | - | - | 1件: 51 51 💬
|
201 | Neramexane mesylate | 1件: Neramexane Neramexane | - | - | - | 1件: 13 13 💬
|
202 | Neratinib | 1件: Neratinib Neratinib | 2件: Neratinib
Neratinib
,
Neratinib maleate
💬
| 3件: EGFR EGFR, ERBB2, ERBB4 💬
| 49件: Adherens junction Adherens junction, Amyotrophic lateral sclerosis, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Coronavirus disease - COVID-19, Cushing syndrome, Endocytosis, Endometrial cancer, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH signaling pathway, HIF-1 signaling pathway, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Tight junction, Virion - Hepatitis viruses 💬 | 1件: 34 34 💬
|
203 | Neridronic acid | 1件: Neridronic Acid Neridronic Acid | - | - | - | 1件: 6 6 💬
|
204 | Nerispirdine | 1件: Nerispirdine Nerispirdine | - | - | - | 1件: 13 13 💬
|
205 | Nerispirdine hydrochloride | 1件: Nerispirdine Nerispirdine | - | - | - | 1件: 13 13 💬
|
206 | Nerixia*IM EV 1F 25MG | - | - | - | - | 1件: 6 6 💬
|
207 | Nerixia*infus IV conc 2F 100MG | - | - | - | - | 1件: 274 274 💬
|
208 | Nerve block | - | - | - | - | 1件: 46 46 💬
|
209 | Nerve growt factor - 2.5S | - | - | - | - | 1件: 90 90 💬
|
210 | Nerve growth factor | 1件: Nerve Growth Factor Nerve Growth Factor | - | - | - | 4件: 2 2, 3, 53, 90 💬
|
211 | Nessuno | - | - | - | - | 1件: 96 96 💬
|
212 | Nestle impact immunonutrition | - | - | - | - | 1件: 97 97 💬
|
213 | NEU-120 | - | - | - | - | 1件: 6 6 💬
|
214 | NEU-411 | - | - | - | - | 1件: 6 6 💬
|
215 | Neupogen | 1件: Filgrastim Filgrastim | 1件: Filgrastim
Filgrastim
💬
| 1件: CSF3R CSF3R 💬
| 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 4件: 13 13, 28, 51, 285 💬
|
216 | Neupro | 1件: Rotigotine Rotigotine | 1件: Rotigotine
Rotigotine
💬
| 1件: DRD2 DRD2 💬
| 10件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
217 | Neupro - 2 MG/24 H + 4 MG/24 H + 6 MG/24 H+ 8 MG/24 H cerotto otto transdermico 7 cerotti + 7 cerotti + 7 cerotti + 7 cerotti trandermici IN bustina | 1件: Rotigotine Rotigotine | 1件: Rotigotine
Rotigotine
💬
| 1件: DRD2 DRD2 💬
| 10件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 127 127 💬
|
218 | Neupro 2 MG/24 H parche transdérmico | 1件: Rotigotine Rotigotine | 1件: Rotigotine
Rotigotine
💬
| 1件: DRD2 DRD2 💬
| 10件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
219 | Neupro 2 MG/24 H transdermal patch | 1件: Rotigotine Rotigotine | 1件: Rotigotine
Rotigotine
💬
| 1件: DRD2 DRD2 💬
| 10件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
220 | Neupro 2MG/24 H transdermal patch | 1件: Rotigotine Rotigotine | 1件: Rotigotine
Rotigotine
💬
| 1件: DRD2 DRD2 💬
| 10件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
221 | Neupro 2MG/24H transdermal patch | 1件: Rotigotine Rotigotine | 1件: Rotigotine
Rotigotine
💬
| 1件: DRD2 DRD2 💬
| 10件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
222 | Neupro 4 MG / 24 HR. transdermal patch | 1件: Rotigotine Rotigotine | 1件: Rotigotine
Rotigotine
💬
| 1件: DRD2 DRD2 💬
| 10件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
223 | Neupro 4 MG/24 H parche transdérmico | 1件: Rotigotine Rotigotine | 1件: Rotigotine
Rotigotine
💬
| 1件: DRD2 DRD2 💬
| 10件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
224 | Neupro 4 MG/24 H transdermal patch | 1件: Rotigotine Rotigotine | 1件: Rotigotine
Rotigotine
💬
| 1件: DRD2 DRD2 💬
| 10件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
225 | Neupro 4MG/24 H transdermal patch | 1件: Rotigotine Rotigotine | 1件: Rotigotine
Rotigotine
💬
| 1件: DRD2 DRD2 💬
| 10件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
226 | Neupro 4MG/24H transdermal patch | 1件: Rotigotine Rotigotine | 1件: Rotigotine
Rotigotine
💬
| 1件: DRD2 DRD2 💬
| 10件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
227 | Neupro 4MG/24HR transdermal patch | - | - | - | - | 1件: 6 6 💬
|
228 | Neupro 6 MG/24 H parche transdérmico | 1件: Rotigotine Rotigotine | 1件: Rotigotine
Rotigotine
💬
| 1件: DRD2 DRD2 💬
| 10件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
229 | Neupro 6 MG/24 H transdermal patch | 1件: Rotigotine Rotigotine | 1件: Rotigotine
Rotigotine
💬
| 1件: DRD2 DRD2 💬
| 10件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
230 | Neupro 6MG/24 H transdermal patch | 1件: Rotigotine Rotigotine | 1件: Rotigotine
Rotigotine
💬
| 1件: DRD2 DRD2 💬
| 10件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
231 | Neupro 6MG/24H transdermal patch | 1件: Rotigotine Rotigotine | 1件: Rotigotine
Rotigotine
💬
| 1件: DRD2 DRD2 💬
| 10件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
232 | Neupro 8 MG/24 H parche transdérmico | 1件: Rotigotine Rotigotine | 1件: Rotigotine
Rotigotine
💬
| 1件: DRD2 DRD2 💬
| 10件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
233 | Neupro 8 MG/24 H transdermal patch | 1件: Rotigotine Rotigotine | 1件: Rotigotine
Rotigotine
💬
| 1件: DRD2 DRD2 💬
| 10件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
234 | Neupro 8MG/24H transdermal patch | 1件: Rotigotine Rotigotine | 1件: Rotigotine
Rotigotine
💬
| 1件: DRD2 DRD2 💬
| 10件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
235 | Neupro*28CER 2MG/24H | 1件: Rotigotine Rotigotine | 1件: Rotigotine
Rotigotine
💬
| 1件: DRD2 DRD2 💬
| 10件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
236 | Neupro*28CER 4MG/24H | 1件: Rotigotine Rotigotine | 1件: Rotigotine
Rotigotine
💬
| 1件: DRD2 DRD2 💬
| 10件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
237 | Neupro*28CER 6MG/24H | 1件: Rotigotine Rotigotine | 1件: Rotigotine
Rotigotine
💬
| 1件: DRD2 DRD2 💬
| 10件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
238 | Neupro*28CER 8MG/24H | 1件: Rotigotine Rotigotine | 1件: Rotigotine
Rotigotine
💬
| 1件: DRD2 DRD2 💬
| 10件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
239 | Neupro*7CER 4MG/24H | 1件: Rotigotine Rotigotine | 1件: Rotigotine
Rotigotine
💬
| 1件: DRD2 DRD2 💬
| 10件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
240 | Neupro*7CER 6MG/24H | 1件: Rotigotine Rotigotine | 1件: Rotigotine
Rotigotine
💬
| 1件: DRD2 DRD2 💬
| 10件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
241 | Neupro*7CER 8MG/24H | 1件: Rotigotine Rotigotine | 1件: Rotigotine
Rotigotine
💬
| 1件: DRD2 DRD2 💬
| 10件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
242 | Neupro® 8 MG/24 H | 1件: Rotigotine Rotigotine | 1件: Rotigotine
Rotigotine
💬
| 1件: DRD2 DRD2 💬
| 10件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
243 | Neuraceq | - | - | - | - | 1件: 6 6 💬
|
244 | Neuro-psychological assessment | - | - | - | - | 1件: 240 240 💬
|
245 | Neurobloc | - | - | - | - | 1件: 6 6 💬
|
246 | Neurocognitive assessment | - | - | - | - | 1件: 6 6 💬
|
247 | Neurocognitive testing | - | - | - | - | 1件: 19 19 💬
|
248 | Neuroepo | - | - | - | - | 1件: 6 6 💬
|
249 | Neurohormonal mechanisms | - | - | - | - | 1件: 127 127 💬
|
250 | Neurological evaluation | - | - | - | - | 1件: 25 25 💬
|
251 | Neurology exam | - | - | - | - | 1件: 19 19 💬
|
252 | Neuromodulation - sacral nerve stimulation | - | - | - | - | 1件: 26 26 💬
|
253 | Neuromuscular electrical stimulation delivered using THE electrical therapy device empi 300 PV | - | - | - | - | 1件: 13 13 💬
|
254 | Neuromuscular evaluation | - | - | - | - | 1件: 13 13 💬
|
255 | Neurontin | 1件: Gabapentin Gabapentin | 1件: Gabapentin
Gabapentin
💬
| 5件: CACNA2D1 CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1 💬
| 10件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Neuroactive ligand signaling, Oxytocin signaling pathway, Synaptic vesicle cycle 💬 | 1件: 13 13 💬
|
256 | Neurontin 300 MG hard capsule | 1件: Gabapentin Gabapentin | 1件: Gabapentin
Gabapentin
💬
| 5件: CACNA2D1 CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1 💬
| 10件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Neuroactive ligand signaling, Oxytocin signaling pathway, Synaptic vesicle cycle 💬 | 1件: 13 13 💬
|
257 | Neuropsychological assessment | - | - | - | - | 1件: 127 127 💬
|
258 | Neuropsychological assessments | - | - | - | - | 1件: 34 34 💬
|
259 | Neurostimulation | - | - | - | - | 1件: 6 6 💬
|
260 | Neurovax | 1件: NeuroVax NeuroVax | - | - | - | 1件: 13 13 💬
|
261 | Neurovax 300UG/ML dose FOR IM injection | 1件: NeuroVax NeuroVax | - | - | - | 1件: 13 13 💬
|
262 | Neurpro | - | - | - | - | 1件: 6 6 💬
|
263 | Neutralizing antibody TO SPK-3006 capsid | - | - | - | - | 1件: 256 256 💬
|
264 | Nevanimibe hydrochloride | 1件: Nevanimibe Nevanimibe | 2件: Nevanimibe
Nevanimibe
,
Nevanimibe hydrochloride
💬
| - | - | 2件: 75 75, 81 💬
|
265 | Nevirapine | 1件: Nevirapine Nevirapine | 1件: Nevirapine
Nevirapine
💬
| - | - | 1件: 265 265 💬
|
266 | NEW formulation adalimumab | - | - | - | - | 1件: 46 46 💬
|
267 | NEW formulation etanercept | - | - | - | - | 1件: 46 46 💬
|
268 | NEW formulation OF rebif - human interferon BETA-1A | 1件: Human interferon beta Human interferon beta | 1件: Interferon beta
Interferon beta
💬
| 2件: IFNAR1 IFNAR1, IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
269 | NEW thermo stable formulation OF epoprostenol sodium | 1件: Epoprostenol Epoprostenol | 2件: Epoprostenol
Epoprostenol
,
Epoprostenol sodium
💬
| 1件: PTGIR PTGIR 💬
| 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | 1件: 86 86 💬
|
270 | Newgam | - | - | - | - | 3件: 14 14, 63, 65 💬
|
271 | Newnorm | - | - | - | - | 1件: 65 65 💬
|
272 | Nexavar | 1件: Sorafenib Sorafenib | 2件: Sorafenib tosylate
Sorafenib tosylate
,
Sorafenib
💬
| 8件: BRAF BRAF, FLT3, FLT4, KDR, KIT, PDGFRB, RAF1, RET 💬
| 87件: Acute myeloid leukemia Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bladder cancer, Breast cancer, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, VEGF signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | 1件: 34 34 💬
|
273 | Nexiguran ziclumeran | - | - | - | - | 1件: 28 28 💬
|
274 | Nexium 10 MG | 1件: Esomeprazole Esomeprazole | 5件: Esomeprazole magnesium
Esomeprazole magnesium
,
Esomeprazole sodium
,
Esomeprazole
,
Esomeprazole strontium
,
Esomeprazole magnesium dihydrate
💬
| 2件: ATP4A ATP4A, ATP4B 💬
| 3件: Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬 | 1件: 234 234 💬
|
275 | Nexium 20 | 1件: Esomeprazole Esomeprazole | 5件: Esomeprazole magnesium
Esomeprazole magnesium
,
Esomeprazole sodium
,
Esomeprazole
,
Esomeprazole strontium
,
Esomeprazole magnesium dihydrate
💬
| 2件: ATP4A ATP4A, ATP4B 💬
| 3件: Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬 | 1件: 299 299 💬
|
276 | Next generation sequencing | - | - | - | - | 1件: 171 171 💬
|
277 | Nexviadyme | 1件: Avalglucosidase alfa Avalglucosidase alfa | 1件: Avalglucosidase alfa
Avalglucosidase alfa
💬
| 1件: GAA GAA 💬
| 3件: Galactose metabolism Galactose metabolism, Lysosome, Starch and sucrose metabolism 💬 | 1件: 256 256 💬
|
278 | NFC-1 | - | - | - | - | 1件: 203 203 💬
|
279 | NFS-02 injection | 1件: NFS-02 NFS-02 | - | - | - | 1件: 302 302 💬
|
280 | NFX-179 GEL | - | - | - | - | 1件: 34 34 💬
|
281 | NG-monomethyl-L-arginine | 1件: Tilarginine Tilarginine | 1件: Tilarginine acetate
Tilarginine acetate
💬
| 3件: NOS1 NOS1, NOS2, NOS3 💬
| 39件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Apelin signaling pathway, Arginine and proline metabolism, Arginine biosynthesis, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Chagas disease, Circadian entrainment, Diabetic cardiomyopathy, Dilated cardiomyopathy, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, HIF-1 signaling pathway, Hormone signaling, Hypertrophic cardiomyopathy, Insulin resistance, Leishmaniasis, Lipid and atherosclerosis, Long-term depression, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Peroxisome, Pertussis, Phagosome, Platelet activation, Relaxin signaling pathway, Salivary secretion, Small cell lung cancer, Sphingolipid signaling pathway, Toxoplasmosis, Tuberculosis, VEGF signaling pathway, Viral myocarditis, cGMP-PKG signaling pathway 💬 | 1件: 67 67 💬
|
282 | NG01 - autologous bone marrow derived human stromal cells | - | - | - | - | 1件: 13 13 💬
|
283 | NGGT002 | - | - | - | - | 1件: 240 240 💬
|
284 | NGGT006 | - | - | - | - | 1件: 79 79 💬
|
285 | NGM282 | - | - | - | - | 2件: 93 93, 94 💬
|
286 | NGN-101 | 1件: NGN-101 NGN-101 | - | - | - | 1件: 19 19 💬
|
287 | NGN-401 | 1件: NGN-401 NGN-401 | - | - | - | 1件: 156 156 💬
|
288 | NGS | - | - | - | - | 1件: 61 61 💬
|
289 | NGX267 | 1件: NGX267 NGX267 | - | - | - | 1件: 53 53 💬
|
290 | NI-0101 | - | - | - | - | 1件: 46 46 💬
|
291 | NI-03 | - | - | - | - | 1件: 298 298 💬
|
292 | NI-0501 | - | - | - | - | 3件: 49 49, 54, 107 💬
|
293 | NI-071 | - | - | - | - | 1件: 46 46 💬
|
294 | NI-0801 | - | - | - | - | 1件: 93 93 💬
|
295 | Niacin | 1件: Niacin Niacin | 1件: Niacin
Niacin
💬
| - | - | 2件: 6 6, 265 💬
|
296 | Niacinamide | 1件: Nicotinamide Nicotinamide | 1件: Niacinamide
Niacinamide
💬
| - | - | 3件: 6 6, 13, 67 💬
|
297 | Nicardipine | 1件: Nicardipine Nicardipine | 2件: Nicardipine hydrochloride
Nicardipine hydrochloride
,
Nicardipine
💬
| 4件: CACNA1C CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
| 37件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 2件: 70 70, 86 💬
|
298 | Niclosamide | 1件: Niclosamide Niclosamide | 1件: Niclosamide
Niclosamide
💬
| - | - | 2件: 46 46, 97 💬
|
299 | Nicolon | - | - | - | - | 1件: 97 97 💬
|
300 | Nicorette 10MG/ 16 H | 1件: Nicotine Nicotine | 2件: Nicotine
Nicotine
,
Nicotine bitartrate
💬
| 16件: CHRNA1 CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG 💬
| 9件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Virion - Ebolavirus, Lyssavirus and Morbillivirus 💬 | 1件: 6 6 💬
|
301 | Nicorette 15 MG/ 16 H | 1件: Nicotine Nicotine | 2件: Nicotine
Nicotine
,
Nicotine bitartrate
💬
| 16件: CHRNA1 CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG 💬
| 9件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Virion - Ebolavirus, Lyssavirus and Morbillivirus 💬 | 1件: 6 6 💬
|
302 | Nicorette 5 MG/ 16 H | 1件: Nicotine Nicotine | 2件: Nicotine
Nicotine
,
Nicotine bitartrate
💬
| 16件: CHRNA1 CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG 💬
| 9件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Virion - Ebolavirus, Lyssavirus and Morbillivirus 💬 | 1件: 6 6 💬
|
303 | Nicotinamid riboside | - | - | - | - | 1件: 13 13 💬
|
304 | Nicotinamide | 1件: Nicotinamide Nicotinamide | 1件: Niacinamide
Niacinamide
💬
| - | - | 5件: 6 6, 18, 49, 107, 162 💬
|
305 | Nicotinamide adenine dinucleotid/nicotinamide mononucleotide | 1件: Nicotinamide Nicotinamide | 1件: Niacinamide
Niacinamide
💬
| - | - | 1件: 63 63 💬
|
306 | Nicotinamide mononucleotide | 2件: Nicotinamide Nicotinamide, Nicotinamide Mononucleotide | 1件: Niacinamide
Niacinamide
💬
| - | - | 1件: 97 97 💬
|
307 | Nicotinamide riboside | 3件: Nicotinamide Nicotinamide, Nicotinamide riboside, Zinc | 1件: Niacinamide
Niacinamide
💬
| - | - | 13件: 2 2, 5, 6, 7, 8, 17, 18, 21, 49, 60, 65, 85, 191 💬
|
308 | Nicotinamide riboside chloride | 2件: Nicotinamide Nicotinamide, Nicotinamide riboside | 1件: Niacinamide
Niacinamide
💬
| - | - | 1件: 97 97 💬
|
309 | Nicotinamide tablet | 1件: Nicotinamide Nicotinamide | 1件: Niacinamide
Niacinamide
💬
| - | - | 1件: 46 46 💬
|
310 | Nicotine | 1件: Nicotine Nicotine | 2件: Nicotine
Nicotine
,
Nicotine bitartrate
💬
| 16件: CHRNA1 CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG 💬
| 9件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Virion - Ebolavirus, Lyssavirus and Morbillivirus 💬 | 1件: 6 6 💬
|
311 | Nicotine and cotinine serum levels | 1件: Nicotine Nicotine | 2件: Nicotine
Nicotine
,
Nicotine bitartrate
💬
| 16件: CHRNA1 CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG 💬
| 9件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Virion - Ebolavirus, Lyssavirus and Morbillivirus 💬 | 1件: 13 13 💬
|
312 | Nicotine dependence | 1件: Nicotine Nicotine | 2件: Nicotine
Nicotine
,
Nicotine bitartrate
💬
| 16件: CHRNA1 CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG 💬
| 9件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Virion - Ebolavirus, Lyssavirus and Morbillivirus 💬 | 1件: 13 13 💬
|
313 | Nicotine GUM | 1件: Nicotine Nicotine | 2件: Nicotine
Nicotine
,
Nicotine bitartrate
💬
| 16件: CHRNA1 CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG 💬
| 9件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Virion - Ebolavirus, Lyssavirus and Morbillivirus 💬 | 1件: 6 6 💬
|
314 | Nicotine patch | 1件: Nicotine Nicotine | 2件: Nicotine
Nicotine
,
Nicotine bitartrate
💬
| 16件: CHRNA1 CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG 💬
| 9件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Virion - Ebolavirus, Lyssavirus and Morbillivirus 💬 | 2件: 6 6, 84 💬
|
315 | Nicotine transdermal patch | 1件: Nicotine Nicotine | 2件: Nicotine
Nicotine
,
Nicotine bitartrate
💬
| 16件: CHRNA1 CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG 💬
| 9件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Virion - Ebolavirus, Lyssavirus and Morbillivirus 💬 | 1件: 6 6 💬
|
316 | Nicotinell 17,5 MG/24-stunden-pflaster | - | - | - | - | 1件: 6 6 💬
|
317 | Nicotinell 35 MG/24-stunden-pflaster | - | - | - | - | 1件: 6 6 💬
|
318 | Nicotinic acid | 1件: Niacin Niacin | 1件: Niacin
Niacin
💬
| - | - | 1件: 79 79 💬
|
319 | NIDO-361 | - | - | - | - | 1件: 1 1 💬
|
320 | Nifedipine | 1件: Nifedipine Nifedipine | 1件: Nifedipine
Nifedipine
💬
| 4件: CACNA1C CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
| 37件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 81 81 💬
|
321 | Nifuroxazide | 1件: Nifuroxazide Nifuroxazide | 1件: Nifuroxazide
Nifuroxazide
💬
| - | - | 1件: 97 97 💬
|
322 | NIL PER OS | - | - | - | - | 1件: 291 291 💬
|
323 | Nilotinib | 1件: Nilotinib Nilotinib | 1件: Nilotinib
Nilotinib
💬
| 4件: ABL1 ABL1, KIT, PDGFRA, PDGFRB 💬
| 32件: Acute myeloid leukemia Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬 | 4件: 6 6, 34, 51, 86 💬
|
324 | Nilotinib 150 MG | 1件: Nilotinib Nilotinib | 1件: Nilotinib
Nilotinib
💬
| 4件: ABL1 ABL1, KIT, PDGFRA, PDGFRB 💬
| 32件: Acute myeloid leukemia Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬 | 1件: 8 8 💬
|
325 | Nilotinib 50 MG | 1件: Nilotinib Nilotinib | 1件: Nilotinib
Nilotinib
💬
| 4件: ABL1 ABL1, KIT, PDGFRA, PDGFRB 💬
| 32件: Acute myeloid leukemia Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬 | 1件: 86 86 💬
|
326 | Nilotinib hydrochloride monohydrate | 1件: Nilotinib Nilotinib | 1件: Nilotinib
Nilotinib
💬
| 4件: ABL1 ABL1, KIT, PDGFRA, PDGFRB 💬
| 32件: Acute myeloid leukemia Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬 | 1件: 34 34 💬
|
327 | Nilvadipine | 1件: Nilvadipine Nilvadipine | 1件: Nilvadipine
Nilvadipine
💬
| 4件: CACNA1C CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
| 37件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 90 90 💬
|
328 | Nimenrix | 1件: Clostridium tetani toxoid antigen (formaldehyde inactivated) Clostridium tetani toxoid antigen (formaldehyde inactivated) | 2件: Tetanus toxoid adsorbed
Tetanus toxoid adsorbed
,
Tetanus toxoid
💬
| - | - | 2件: 50 50, 61 💬
|
329 | Nimesulide | 1件: Nimesulide Nimesulide | 1件: Nimesulide
Nimesulide
💬
| 1件: PTGS2 PTGS2 💬
| 22件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 46 46 💬
|
330 | Ninlaro | - | - | - | - | 1件: 61 61 💬
|
331 | Nintedanib | 1件: Nintedanib Nintedanib | 2件: Nintedanib esylate
Nintedanib esylate
,
Nintedanib
💬
| 8件: FGFR1 FGFR1, FGFR2, FGFR3, FLT1, FLT4, KDR, PDGFRA, PDGFRB 💬
| 33件: Adherens junction Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, Endocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Gastric cancer, Glioma, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Transcriptional misregulation in cancer, VEGF signaling pathway 💬 | 7件: 51 51, 84, 85, 89, 227, 228, 331 💬
|
332 | Nintedanib 150 MG and 100 MG soft capsules | 1件: Nintedanib Nintedanib | 2件: Nintedanib esylate
Nintedanib esylate
,
Nintedanib
💬
| 8件: FGFR1 FGFR1, FGFR2, FGFR3, FLT1, FLT4, KDR, PDGFRA, PDGFRB 💬
| 33件: Adherens junction Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, Endocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Gastric cancer, Glioma, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Transcriptional misregulation in cancer, VEGF signaling pathway 💬 | 1件: 227 227 💬
|
333 | Nintendo WII FIT balance board | - | - | - | - | 1件: 13 13 💬
|
334 | Nintendo WII FIT balance exercises | 1件: Isoxaflutole Isoxaflutole | - | - | - | 1件: 13 13 💬
|
335 | Nintédanib | - | - | - | - | 1件: 227 227 💬
|
336 | Niox mino® airway inflammation monitor | - | - | - | - | 1件: 98 98 💬
|
337 | NIP292 tablet | - | - | - | - | 1件: 85 85 💬
|
338 | NIP292 tablets | - | - | - | - | 1件: 85 85 💬
|
339 | Nipocalimab | 1件: Nipocalimab Nipocalimab | 1件: Nipocalimab
Nipocalimab
💬
| - | - | 6件: 11 11, 14, 46, 49, 53, 61 💬
|
340 | Nipocalimab | 1件: Nipocalimab Nipocalimab | 1件: Nipocalimab
Nipocalimab
💬
| - | - | 1件: 11 11 💬
|
341 | Nirs after bosentan administration | - | - | - | - | 1件: 13 13 💬
|
342 | Nirs baseline | - | - | - | - | 1件: 13 13 💬
|
343 | Nitazoxanide | 1件: Nitazoxanide Nitazoxanide | 1件: Nitazoxanide
Nitazoxanide
💬
| - | - | 1件: 96 96 💬
|
344 | Nitazoxanide 500MG oral tablet | 1件: Nitazoxanide Nitazoxanide | 1件: Nitazoxanide
Nitazoxanide
💬
| - | - | 1件: 46 46 💬
|
345 | Nitisinone | 1件: Nitisinone Nitisinone | 1件: Nitisinone
Nitisinone
💬
| 1件: HPD HPD 💬
| 3件: Phenylalanine metabolism Phenylalanine metabolism, Tyrosine metabolism, Ubiquinone and other terpenoid-quinone biosynthesis 💬 | 3件: 6 6, 164, 241 💬
|
346 | Nitisinone 10 MG tablet high compritol | 1件: Nitisinone Nitisinone | 1件: Nitisinone
Nitisinone
💬
| 1件: HPD HPD 💬
| 3件: Phenylalanine metabolism Phenylalanine metabolism, Tyrosine metabolism, Ubiquinone and other terpenoid-quinone biosynthesis 💬 | 1件: 241 241 💬
|
347 | Nitisinone baked tablet | 1件: Nitisinone Nitisinone | 1件: Nitisinone
Nitisinone
💬
| 1件: HPD HPD 💬
| 3件: Phenylalanine metabolism Phenylalanine metabolism, Tyrosine metabolism, Ubiquinone and other terpenoid-quinone biosynthesis 💬 | 1件: 241 241 💬
|
348 | Nitrate | 1件: Nitrate Nitrate | 1件: Nitric acid
Nitric acid
💬
| - | - | 1件: 299 299 💬
|
349 | Nitrate-depleted beetroot juice | 1件: Nitrate Nitrate | 1件: Nitric acid
Nitric acid
💬
| - | - | 1件: 67 67 💬
|
350 | Nitrate-rich beetroot juice (70ML with approx. 400 MG nitrate) twice A DAY FOR 3 days | 1件: Nitrate Nitrate | 1件: Nitric acid
Nitric acid
💬
| - | - | 1件: 85 85 💬
|
351 | Nitric oxide | 1件: Nitric Oxide Nitric Oxide | 1件: Nitric oxide
Nitric oxide
💬
| - | - | 8件: 51 51, 85, 86, 88, 97, 210, 294, 299 💬
|
352 | Nitric oxide 160 PPM | 1件: Nitric Oxide Nitric Oxide | 1件: Nitric oxide
Nitric oxide
💬
| - | - | 1件: 299 299 💬
|
353 | Nitric oxide FOR inhalation | 1件: Nitric Oxide Nitric Oxide | 1件: Nitric oxide
Nitric oxide
💬
| - | - | 2件: 86 86, 299 💬
|
354 | Nitric oxide generated BY THE geno nitrosyl delivery system | 1件: Nitric Oxide Nitric Oxide | 1件: Nitric oxide
Nitric oxide
💬
| - | - | 1件: 86 86 💬
|
355 | Nitric oxide plus oxygen | 2件: Nitric Oxide Nitric Oxide, Oxygen | 2件: Oxygen
Oxygen
,
Nitric oxide
💬
| - | - | 1件: 86 86 💬
|
356 | Nitric oxide supplement | 1件: Nitric Oxide Nitric Oxide | 1件: Nitric oxide
Nitric oxide
💬
| - | - | 1件: 251 251 💬
|
357 | Nitrofurantoin | 1件: Nitrofurantoin Nitrofurantoin | 1件: Nitrofurantoin
Nitrofurantoin
💬
| - | - | 1件: 13 13 💬
|
358 | Nitrogen | 1件: Nitrogen Nitrogen | 1件: Nitrogen
Nitrogen
💬
| - | - | 5件: 5 5, 6, 17, 211, 299 💬
|
359 | Nitroglycerin | 1件: Nitroglycerin Nitroglycerin | 1件: Nitroglycerin
Nitroglycerin
💬
| - | - | 1件: 51 51 💬
|
360 | Nitroglycerine GEL | 1件: Nitroglycerin Nitroglycerin | 1件: Nitroglycerin
Nitroglycerin
💬
| - | - | 1件: 51 51 💬
|
361 | Nitrous oxide | 1件: Nitrous oxide Nitrous oxide | 1件: Nitrous oxide
Nitrous oxide
💬
| - | - | 1件: 34 34 💬
|
362 | Niubangzi pill | - | - | - | - | 1件: 46 46 💬
|
363 | Nivolumab | 1件: Nivolumab Nivolumab | 1件: Nivolumab
Nivolumab
💬
| 1件: PDCD1 PDCD1 💬
| 3件: Cell adhesion molecules Cell adhesion molecules, PD-L1 expression and PD-1 checkpoint pathway in cancer, T cell receptor signaling pathway 💬 | 12件: 13 13, 26, 41, 46, 49, 50, 51, 53, 85, 96, 97, 159 💬
|
364 | Nizoral | 1件: Ketoconazole Ketoconazole | 1件: Ketoconazole
Ketoconazole
💬
| - | - | 1件: 75 75 💬
|
365 | NJ-tube: silicon ED tube | - | - | - | - | 1件: 6 6 💬
|
366 | NK 010 or NK042 | - | - | - | - | 1件: 49 49 💬
|
367 | NK cells | 1件: Natural Killer Cell Natural Killer Cell | - | - | - | 3件: 26 26, 49, 63 💬
|
368 | NKX019 | - | - | - | - | 2件: 49 49, 51 💬
|
369 | NL-chchd-001 | - | - | - | - | 1件: 2 2 💬
|
370 | NL-FLVC-001 | - | - | - | - | 1件: 90 90 💬
|
371 | NLE4-D-PHE7-alpha-MSH | - | - | - | - | 1件: 254 254 💬
|
372 | NLX-112 | - | - | - | - | 1件: 6 6 💬
|
373 | NLY01 | - | - | - | - | 1件: 6 6 💬
|
374 | NM8074 | - | - | - | - | 4件: 50 50, 62, 66, 109 💬
|
375 | NMD670 | - | - | - | - | 3件: 3 3, 10, 11 💬
|
376 | Nmda | 1件: Ketamine Ketamine | 2件: Ketamine hydrochloride
Ketamine hydrochloride
,
Ketamine
💬
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| 21件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
377 | NN 1841 | - | - | - | - | 1件: 288 288 💬
|
378 | NN1841 | - | - | - | - | 1件: 288 288 💬
|
379 | NNC 0109-0000-0012 | - | - | - | - | 1件: 46 46 💬
|
380 | NNC 0141-0000-0100 | - | - | - | - | 1件: 46 46 💬
|
381 | NNC 0142-0000-0002 | - | - | - | - | 2件: 46 46, 96 💬
|
382 | NNC 0151-0000-0000 | - | - | - | - | 2件: 46 46, 49 💬
|
383 | NNC 142-0002 | - | - | - | - | 1件: 46 46 💬
|
384 | NNC0109-0012 | - | - | - | - | 1件: 46 46 💬
|
385 | NNC0114-0000-0005 | - | - | - | - | 1件: 46 46 💬
|
386 | NNC0114-0006 | 1件: NNC0114-0006 NNC0114-0006 | - | - | - | 3件: 46 46, 49, 96 💬
|
387 | NNC0142-0000-0002 | - | - | - | - | 1件: 96 96 💬
|
388 | NNC0142-0002 | - | - | - | - | 1件: 46 46 💬
|
389 | NNC0151-0000-0000 | - | - | - | - | 1件: 46 46 💬
|
390 | NNC0215-0384 | - | - | - | - | 2件: 46 46, 162 💬
|
391 | NNC109-0012 | - | - | - | - | 1件: 46 46 💬
|
392 | NNC142-0002 | - | - | - | - | 1件: 96 96 💬
|
393 | NNC151-0000 | - | - | - | - | 1件: 46 46 💬
|
394 | NNZ-2566 | - | - | - | - | 2件: 156 156, 206 💬
|
395 | NNZ-2591 | 1件: NNZ-2591 NNZ-2591 | - | - | - | 2件: 193 193, 201 💬
|
396 | NO active treatment | - | - | - | - | 1件: 274 274 💬
|
397 | NO ANTI-inflammatory treatment | - | - | - | - | 1件: 271 271 💬
|
398 | NO doxycycline | 1件: Doxycycline Doxycycline | 5件: Doxycycline
Doxycycline
,
Doxycycline hyclate
,
Doxycycline calcium
,
Doxycycline
,
Doxycycline hydrochloride
💬
| - | - | 1件: 299 299 💬
|
399 | NO enzyme therapy | - | - | - | - | 1件: 298 298 💬
|
400 | NO intervention, will NOT receive ANY active study intervention | - | - | - | - | 2件: 90 90, 303 💬
|
401 | NO intervention- observational SUB-study | - | - | - | - | 1件: 226 226 💬
|
402 | NO interventional drug product utilized IN this follow-UP study | - | - | - | - | 1件: 20 20 💬
|
403 | NO investigational product | - | - | - | - | 1件: 19 19 💬
|
404 | NO IT treatment | - | - | - | - | 1件: 19 19 💬
|
405 | NO pancreatic enzyme replacement therapy | - | - | - | - | 1件: 299 299 💬
|
406 | NO plasma exchange | - | - | - | - | 2件: 43 43, 44 💬
|
407 | NO treatment | - | - | - | - | 2件: 53 53, 274 💬
|
408 | NO treatment ARM | - | - | - | - | 1件: 13 13 💬
|
409 | NO4bd03 | - | - | - | - | 1件: 6 6 💬
|
410 | Nociceptor flexor reflex | - | - | - | - | 1件: 149 149 💬
|
411 | Nocturnal oxygen , nocturnal BI-level positive pressure ventilation | - | - | - | - | 1件: 299 299 💬
|
412 | NOE-101 | - | - | - | - | 1件: 158 158 💬
|
413 | Nolpitantium besylate | - | - | - | - | 1件: 97 97 💬
|
414 | Nomacopan | 1件: Nomacopan Nomacopan | 1件: Nomacopan
Nomacopan
💬
| 1件: C5 C5 💬
| 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 1件: 162 162 💬
|
415 | Nomegestrol | 1件: Nomegestrol Nomegestrol | 1件: Nomegestrol
Nomegestrol
💬
| 1件: PGR PGR 💬
| 5件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬 | 1件: 13 13 💬
|
416 | Nomegestrol acetate | 2件: Nomegestrol Nomegestrol, Nomegestrol acetate | 2件: Nomegestrol
Nomegestrol
,
Nomegestrol acetate
💬
| 1件: PGR PGR 💬
| 5件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬 | 1件: 13 13 💬
|
417 | Nomlabofusp | 1件: Nomlabofusp Nomlabofusp | - | - | - | 1件: 18 18 💬
|
418 | NON applicabile | - | - | - | - | 3件: 49 49, 51, 256 💬
|
419 | NON applicable | - | - | - | - | 2件: 10 10, 19 💬
|
420 | NON AS OF YET | - | - | - | - | 1件: 97 97 💬
|
421 | NON ATG conditioning regimen | - | - | - | - | 1件: 60 60 💬
|
422 | NON commercial | - | - | - | - | 1件: 75 75 💬
|
423 | NON disponibile | - | - | - | - | 2件: 13 13, 201 💬
|
424 | NON intervention-genetic testing | - | - | - | - | 1件: 6 6 💬
|
425 | NON intervention-monitoring device | - | - | - | - | 1件: 6 6 💬
|
426 | NON invasive prenatal diagnosis | - | - | - | - | 3件: 8 8, 113, 206 💬
|
427 | NON invasive ventilation | - | - | - | - | 1件: 299 299 💬
|
428 | NON propietry, therefore N/A | - | - | - | - | 1件: 51 51 💬
|
429 | NON-active stimulation | - | - | - | - | 1件: 46 46 💬
|
430 | NON-ANTI-TNF biologics | - | - | - | - | 2件: 46 46, 271 💬
|
431 | NON-biologic ANTI-rheumatic drugs | - | - | - | - | 1件: 46 46 💬
|
432 | NON-biologic dmards | - | - | - | - | 3件: 46 46, 86, 107 💬
|
433 | NON-biological dmards | - | - | - | - | 1件: 46 46 💬
|
434 | NON-enteric coated pancreatic enzyme preparation | - | - | - | - | 1件: 298 298 💬
|
435 | NON-exposed group | - | - | - | - | 1件: 97 97 💬
|
436 | NON-genotyping | - | - | - | - | 1件: 97 97 💬
|
437 | NON-hormonal period | - | - | - | - | 1件: 299 299 💬
|
438 | NON-mavacamten symptomatic ohcm therapy | 1件: Mavacamten Mavacamten | 1件: Mavacamten
Mavacamten
💬
| 1件: MYH6_7 MYH6_7 💬
| 9件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Cardiac muscle contraction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Motor proteins, Thyroid hormone signaling pathway, Viral myocarditis, cGMP-PKG signaling pathway 💬 | 1件: 58 58 💬
|
439 | NON-motor symptoms | - | - | - | - | 1件: 6 6 💬
|
440 | NON-nucleoside reverse transcriptase inhibitors | - | - | - | - | 1件: 265 265 💬
|
441 | NON-pegylated interferon | - | - | - | - | 1件: 13 13 💬
|
442 | NON-steroidal ANTI-inflammatory drug | - | - | - | - | 1件: 46 46 💬
|
443 | NON-steroidal ANTI-inflammatory drugs | - | - | - | - | 1件: 46 46 💬
|
444 | NON-steroidal mineralocorticoid receptor antagonist and SOC | - | - | - | - | 1件: 66 66 💬
|
445 | NON-TNFI-biologic class | - | - | - | - | 1件: 46 46 💬
|
446 | Nonbiologic dmards OF investigator'S choice | - | - | - | - | 1件: 46 46 💬
|
447 | None AS OF YET | - | - | - | - | 1件: 46 46 💬
|
448 | None assigned | - | - | - | - | 2件: 231 231, 299 💬
|
449 | None AT this time | - | - | - | - | 2件: 96 96, 140 💬
|
450 | None given | - | - | - | - | 1件: 97 97 💬
|
451 | None YET | - | - | - | - | 3件: 51 51, 85, 222 💬
|
452 | Noninvasive actigraphy monitor | - | - | - | - | 1件: 86 86 💬
|
453 | Nonmyeloablative allogeneic hematopoietic stem cell transplantation | - | - | - | - | 6件: 28 28, 51, 60, 62, 65, 285 💬
|
454 | Norantipyrine | - | - | - | - | 1件: 2 2 💬
|
455 | Nordimet 7,5 MG solution injectable EN stylo PRérempli | 1件: Methotrexate Methotrexate | 2件: Methotrexate
Methotrexate
,
Methotrexate sodium
💬
| 2件: DHFR DHFR, DHFR 💬
| 3件: Folate biosynthesis Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬 | 1件: 46 46 💬
|
456 | Norditropin | 1件: Somatotropin Somatotropin | 1件: Somatropin
Somatropin
💬
| 1件: GHR GHR 💬
| 6件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | 1件: 195 195 💬
|
457 | Norditropin 24 IU | 1件: Somatotropin Somatotropin | 1件: Somatropin
Somatropin
💬
| 1件: GHR GHR 💬
| 6件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | 1件: 195 195 💬
|
458 | Norditropin flexpro 10 MG/1.5 ML, solution FOR injection IN PRE-filled PEN | 1件: Somatotropin Somatotropin | 1件: Somatropin
Somatropin
💬
| 1件: GHR GHR 💬
| 6件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | 1件: 195 195 💬
|
459 | Norditropin simplexx | 1件: Somatotropin Somatotropin | 1件: Somatropin
Somatropin
💬
| 1件: GHR GHR 💬
| 6件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | 3件: 97 97, 193, 195 💬
|
460 | Norditropin simplexx 15 MG/1.5 ML | 1件: Somatotropin Somatotropin | 1件: Somatropin
Somatropin
💬
| 1件: GHR GHR 💬
| 6件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | 1件: 3 3 💬
|
461 | Norditropin simplexx 5MG/1.5ML | 1件: Somatotropin Somatotropin | 1件: Somatropin
Somatropin
💬
| 1件: GHR GHR 💬
| 6件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | 1件: 107 107 💬
|
462 | Norditropine simplex | - | - | - | - | 1件: 238 238 💬
|
463 | Norditropin® simplexx® 5MG/1.5ML | 1件: Somatotropin Somatotropin | 1件: Somatropin
Somatropin
💬
| 1件: GHR GHR 💬
| 6件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | 1件: 97 97 💬
|
464 | Norepinephrine | 1件: Norepinephrine Norepinephrine | 3件: Noradrenaline
Noradrenaline
,
Norepinephrine bitartrate
,
Norepinephrine hydrochoride
💬
| 9件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬
| 16件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 22 22 💬
|
465 | Norepinephrine bitartrate | 1件: Norepinephrine Norepinephrine | 3件: Noradrenaline
Noradrenaline
,
Norepinephrine bitartrate
,
Norepinephrine hydrochoride
💬
| 9件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬
| 16件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 296 296 💬
|
466 | Norethindrone | 1件: Norethisterone Norethisterone | 2件: Norethindrone
Norethindrone
,
Norethindrone acetate
💬
| 1件: PGR PGR 💬
| 5件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬 | 4件: 13 13, 46, 49, 299 💬
|
467 | Normal (control) diet | - | - | - | - | 1件: 240 240 💬
|
468 | Normal diet | - | - | - | - | 2件: 96 96, 97 💬
|
469 | Normal dietetic scheme | - | - | - | - | 1件: 97 97 💬
|
470 | Normal human immunoglobulin G | - | - | - | - | 1件: 65 65 💬
|
471 | Normal oral intake OF THE traditional formula | - | - | - | - | 1件: 296 296 💬
|
472 | Normal saline | - | - | - | - | 20件: 6 6, 13, 17, 22, 36, 46, 49, 60, 70, 94, 96, 97, 210, 211, 222, 226, 276, 280, 296, 299 💬
|
473 | Normal saline 0.9% infusion solution | - | - | - | - | 1件: 22 22 💬
|
474 | Normal saline enema | - | - | - | - | 1件: 97 97 💬
|
475 | Normal saline FOR injection | - | - | - | - | 2件: 13 13, 84 💬
|
476 | Normal saline instillation | - | - | - | - | 1件: 226 226 💬
|
477 | Normal saline IV administration | - | - | - | - | 1件: 65 65 💬
|
478 | Normal saline IV, salt tablets | - | - | - | - | 1件: 299 299 💬
|
479 | Normal saline solution | 1件: Sodium chloride Sodium chloride | 1件: Sodium chloride
Sodium chloride
💬
| - | - | 1件: 299 299 💬
|
480 | Normix*AD 12CPR RIV 200MG | - | - | - | - | 1件: 96 96 💬
|
481 | Norovirus -specific T-cell (NST) therapy | - | - | - | - | 1件: 65 65 💬
|
482 | Norphenazone | 1件: Edaravone Edaravone | 1件: Edaravone
Edaravone
💬
| - | - | 1件: 2 2 💬
|
483 | Northera | 1件: Droxidopa Droxidopa | 1件: Droxidopa
Droxidopa
💬
| 9件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬
| 16件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 6 6 💬
|
484 | Nortriptyline | 1件: Nortriptyline Nortriptyline | 2件: Nortriptyline hydrochloride
Nortriptyline hydrochloride
,
Nortriptyline
💬
| 2件: SLC6A2 SLC6A2, SLC6A4 💬
| 3件: Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬 | 2件: 6 6, 226 💬
|
485 | Nortriptyline hydrochloride | 1件: Nortriptyline Nortriptyline | 2件: Nortriptyline hydrochloride
Nortriptyline hydrochloride
,
Nortriptyline
💬
| 2件: SLC6A2 SLC6A2, SLC6A4 💬
| 3件: Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 6 6 💬
|
486 | Norucholic acid | 1件: norUrsodeoxycholic acid norUrsodeoxycholic acid | - | - | - | 1件: 94 94 💬
|
487 | Norucholic acid (NCA) 500 MG | 1件: norUrsodeoxycholic acid norUrsodeoxycholic acid | - | - | - | 1件: 93 93 💬
|
488 | Norudca | - | - | - | - | 1件: 94 94 💬
|
489 | Norursodeoxycholic acid | 1件: norUrsodeoxycholic acid norUrsodeoxycholic acid | - | - | - | 1件: 94 94 💬
|
490 | Norursodeoxycholic acid, NCA | 1件: norUrsodeoxycholic acid norUrsodeoxycholic acid | - | - | - | 1件: 94 94 💬
|
491 | Norvir | 1件: Ritonavir Ritonavir | 1件: Ritonavir
Ritonavir
💬
| - | - | 1件: 265 265 💬
|
492 | Norvir 100 MG FILM-coated tablets | - | - | - | - | 1件: 299 299 💬
|
493 | NOT applicable | - | - | - | - | 1件: 13 13 💬
|
494 | NOT YET assigned | - | - | - | - | 2件: 36 36, 97 💬
|
495 | Novantrone*INF 2MG/ML 5ML | 1件: Mitoxantrone Mitoxantrone | 2件: Mitoxantrone hydrochloride
Mitoxantrone hydrochloride
,
Mitoxantrone
💬
| - | - | 1件: 13 13 💬
|
496 | Novartis pharmaceuticals corporation | - | - | - | - | 1件: 13 13 💬
|
497 | Novatrex | - | - | - | - | 1件: 13 13 💬
|
498 | Novo rapid | - | - | - | - | 1件: 299 299 💬
|
499 | Novolin-R insulin | - | - | - | - | 1件: 127 127 💬
|
500 | Novonorm 0.5 MG | - | - | - | - | 1件: 299 299 💬
|
501 | Novonorm 1 MG | - | - | - | - | 1件: 299 299 💬
|
502 | Novonorm 2 MG | - | - | - | - | 1件: 299 299 💬
|
503 | Novorapid / humalog short acting insulin | - | - | - | - | 1件: 299 299 💬
|
504 | Novorapid aspartate | - | - | - | - | 1件: 299 299 💬
|
505 | NOW foods L-ornithine capsules | - | - | - | - | 1件: 96 96 💬
|
506 | NOX-E36 | - | - | - | - | 1件: 49 49 💬
|
507 | Noxafil | 1件: Posaconazole Posaconazole | 1件: Posaconazole
Posaconazole
💬
| - | - | 1件: 299 299 💬
|
508 | Noxafil - 40 MG/ML sospensione orale USO orale flacone (vetro) 105 ML 1 flacone | - | - | - | - | 1件: 299 299 💬
|
509 | Noxafil - oral suspension 40 MG/ML | 1件: Posaconazole Posaconazole | 1件: Posaconazole
Posaconazole
💬
| - | - | 1件: 299 299 💬
|
510 | Noxafil 100 MG | 1件: Posaconazole Posaconazole | 1件: Posaconazole
Posaconazole
💬
| - | - | 1件: 299 299 💬
|
511 | Noxafil 100 MG tablets gastro-resistant | 1件: Posaconazole Posaconazole | 1件: Posaconazole
Posaconazole
💬
| - | - | 1件: 299 299 💬
|
512 | Noxafil 40 MG/ML oral solution | 1件: Posaconazole Posaconazole | 1件: Posaconazole
Posaconazole
💬
| - | - | 1件: 65 65 💬
|
513 | Noxafil gastro resistant tablets | - | - | - | - | 1件: 60 60 💬
|
514 | NP001 | - | - | - | - | 2件: 2 2, 17 💬
|
515 | NP031112 600MG | - | - | - | - | 1件: 5 5 💬
|
516 | NP031112 800MG | - | - | - | - | 1件: 5 5 💬
|
517 | NPB-01 | - | - | - | - | 3件: 13 13, 14, 162 💬
|
518 | NPC transplantation | - | - | - | - | 1件: 6 6 💬
|
519 | NPC-02 | - | - | - | - | 1件: 171 171 💬
|
520 | NPC-09 | - | - | - | - | 1件: 30 30 💬
|
521 | NPC-12G GEL | - | - | - | - | 2件: 34 34, 158 💬
|
522 | NPC-12Y GEL | - | - | - | - | 1件: 158 158 💬
|
523 | NPC-14 | - | - | - | - | 1件: 113 113 💬
|
524 | NPI-001 | - | - | - | - | 2件: 90 90, 303 💬
|
525 | NPL-2009 | - | - | - | - | 1件: 206 206 💬
|
526 | Nplate | 1件: Romiplostim Romiplostim | 1件: Romiplostim
Romiplostim
💬
| 1件: TPOR TPOR 💬
| 3件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | 2件: 60 60, 63 💬
|
527 | Nplate 500 microgramos polvo para solucióN inyectable | 1件: Romiplostim Romiplostim | 1件: Romiplostim
Romiplostim
💬
| 1件: TPOR TPOR 💬
| 3件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | 1件: 63 63 💬
|
528 | Npsp 558 | - | - | - | - | 1件: 235 235 💬
|
529 | NPSP558 | - | - | - | - | 1件: 235 235 💬
|
530 | NR082 injection | - | - | - | - | 1件: 302 302 💬
|
531 | NS | - | - | - | - | 1件: 96 96 💬
|
532 | NS 2330 | - | - | - | - | 1件: 6 6 💬
|
533 | NS-050/NCNP-03 | - | - | - | - | 1件: 113 113 💬
|
534 | NS-065/NCNP-01 | - | - | - | - | 1件: 113 113 💬
|
535 | NS-089/NCNP-02 | - | - | - | - | 1件: 113 113 💬
|
536 | NS-229 | - | - | - | - | 2件: 44 44, 45 💬
|
537 | NS-304 | - | - | - | - | 1件: 86 86 💬
|
538 | NS2330 | - | - | - | - | 1件: 6 6 💬
|
539 | Nsaid | - | - | - | - | 2件: 270 270, 271 💬
|
540 | Nsaids | - | - | - | - | 4件: 46 46, 70, 107, 271 💬
|
541 | Nsaids and sulfasalazine | - | - | - | - | 1件: 271 271 💬
|
542 | Nsnsaids | - | - | - | - | 2件: 107 107, 271 💬
|
543 | NSP001 | - | - | - | - | 1件: 96 96 💬
|
544 | NT 101 | - | - | - | - | 4件: 5 5, 6, 7, 17 💬
|
545 | NT-501 | 1件: Ciliary neurotrophic factor Ciliary neurotrophic factor | - | - | - | 2件: 90 90, 303 💬
|
546 | NT-I7 | 1件: Efineptakin alfa Efineptakin alfa | 1件: Efineptakin alfa
Efineptakin alfa
💬
| - | - | 1件: 25 25 💬
|
547 | NT-KO-003 | - | - | - | - | 1件: 13 13 💬
|
548 | Ntbc | - | - | - | - | 1件: 241 241 💬
|
549 | Ntcell implantation | - | - | - | - | 1件: 6 6 💬
|
550 | NTI164 | - | - | - | - | 1件: 156 156 💬
|
551 | NTLA-2001 | 1件: NTLA-2001 NTLA-2001 | - | - | - | 1件: 28 28 💬
|
552 | NTLA-2002 | 1件: NTLA-2002 NTLA-2002 | - | - | - | 1件: 65 65 💬
|
553 | NTQ5082 | - | - | - | - | 1件: 62 62 💬
|
554 | NTQ5082 capsules 100 MG | - | - | - | - | 1件: 66 66 💬
|
555 | NTQ5082 capsules 200 MG | - | - | - | - | 1件: 66 66 💬
|
556 | NTQ5082 capsules 300 MG | - | - | - | - | 1件: 66 66 💬
|
557 | NU100 | - | - | - | - | 1件: 13 13 💬
|
558 | Nucala | 1件: Mepolizumab Mepolizumab | 1件: Mepolizumab
Mepolizumab
💬
| 1件: IL5 IL5 💬
| 13件: Allograft rejection Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬 | 2件: 44 44, 45 💬
|
559 | Nucala 100 MG powder FOR solution FOR injection | 1件: Mepolizumab Mepolizumab | 1件: Mepolizumab
Mepolizumab
💬
| 1件: IL5 IL5 💬
| 13件: Allograft rejection Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬 | 2件: 44 44, 45 💬
|
560 | Nucel | - | - | - | - | 1件: 70 70 💬
|
561 | Nucleomaxx | - | - | - | - | 1件: 265 265 💬
|
562 | Nucleoside analogue sparing haart regimen | - | - | - | - | 1件: 265 265 💬
|
563 | Nuedexta | - | - | - | - | 1件: 2 2 💬
|
564 | Nulojix | - | - | - | - | 1件: 46 46 💬
|
565 | Numerical rating scale | - | - | - | - | 1件: 46 46 💬
|
566 | Nuplazid | 1件: Pimavanserin Pimavanserin | 1件: Pimavanserin tartrate
Pimavanserin tartrate
💬
| 2件: HTR2 HTR2, HTR2 💬
| 6件: Calcium signaling pathway Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse 💬 | 1件: 6 6 💬
|
567 | Nuplazid 34 MG oral capsule | 1件: Pimavanserin Pimavanserin | 1件: Pimavanserin tartrate
Pimavanserin tartrate
💬
| 2件: HTR2 HTR2, HTR2 💬
| 6件: Calcium signaling pathway Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse 💬 | 1件: 6 6 💬
|
568 | Nursinersen | - | - | - | - | 1件: 3 3 💬
|
569 | Nusinersen | 1件: Nusinersen Nusinersen | 2件: Nusinersen sodium
Nusinersen sodium
,
Nusinersen
💬
| - | - | 1件: 3 3 💬
|
570 | Nusinersen injectable product | 1件: Nusinersen Nusinersen | 2件: Nusinersen sodium
Nusinersen sodium
,
Nusinersen
💬
| - | - | 1件: 3 3 💬
|
571 | Nusinersen sodium | 1件: Nusinersen Nusinersen | 2件: Nusinersen sodium
Nusinersen sodium
,
Nusinersen
💬
| - | - | 1件: 3 3 💬
|
572 | Nusinersen treatments | 1件: Nusinersen Nusinersen | 2件: Nusinersen sodium
Nusinersen sodium
,
Nusinersen
💬
| - | - | 1件: 3 3 💬
|
573 | Nutraceutical combination | - | - | - | - | 1件: 96 96 💬
|
574 | Nutridrink-impact | - | - | - | - | 1件: 299 299 💬
|
575 | Nutrition counseling | - | - | - | - | 1件: 298 298 💬
|
576 | Nutrition specialist | - | - | - | - | 1件: 97 97 💬
|
577 | Nutrition supplement | - | - | - | - | 1件: 97 97 💬
|
578 | Nutrition treat | - | - | - | - | 1件: 96 96 💬
|
579 | Nutritional assessment | - | - | - | - | 1件: 6 6 💬
|
580 | Nutritional dietary intervention | - | - | - | - | 2件: 96 96, 97 💬
|
581 | Nutritional formulation containing exogenous ketones | - | - | - | - | 1件: 201 201 💬
|
582 | Nutritional ketone supplement | - | - | - | - | 2件: 317 317, 344 💬
|
583 | Nutritional supplement | - | - | - | - | 1件: 90 90 💬
|
584 | Nutropin AQ | 1件: Somatotropin Somatotropin | 1件: Somatropin
Somatropin
💬
| 1件: GHR GHR 💬
| 6件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | 4件: 78 78, 134, 193, 299 💬
|
585 | Nutropinaq 10MG/2ML (30 I.E.) injektionsllösung | 1件: Somatotropin Somatotropin | 1件: Somatropin
Somatropin
💬
| 1件: GHR GHR 💬
| 6件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | 1件: 65 65 💬
|
586 | Nutropinaq 10MG/2ML solution FOR injection | 1件: Somatotropin Somatotropin | 1件: Somatropin
Somatropin
💬
| 1件: GHR GHR 💬
| 6件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | 1件: 96 96 💬
|
587 | NV1205 | - | - | - | - | 1件: 20 20 💬
|
588 | NVF233 | - | - | - | - | 1件: 13 13 💬
|
589 | NW-1015 | - | - | - | - | 1件: 6 6 💬
|
590 | NW-1015E, EMD 1195686, MSC2191632B | - | - | - | - | 1件: 6 6 💬
|
591 | NX-13 250 MG | - | - | - | - | 1件: 97 97 💬
|
592 | NX-13 250MG | - | - | - | - | 1件: 97 97 💬
|
593 | NX-13 250MG IR | - | - | - | - | 1件: 97 97 💬
|
594 | NX-13 500MG IR | - | - | - | - | 1件: 97 97 💬
|
595 | NX-13 500MG MR | - | - | - | - | 1件: 97 97 💬
|
596 | NX-13 750MG | - | - | - | - | 1件: 97 97 💬
|
597 | NX1011 | - | - | - | - | 1件: 86 86 💬
|
598 | NX210C | - | - | - | - | 1件: 2 2 💬
|
599 | NXC-201 CAR-T | - | - | - | - | 1件: 28 28 💬
|
600 | NYX-458 | - | - | - | - | 1件: 6 6 💬
|
601 | Nébivolol | - | - | - | - | 1件: 113 113 💬
|